SCHEMBL30023697

SCHEMBL30023697

O=C1CCCc2oc(=O)c3cc(F)ccc3c21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.49
PIM3 Q86V86 1/20 0.49
ALDH1A1 P00352 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
CDC25A P30304 2/20 0.35
CDC25C P30307 2/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
GABRP O00591 2/20 0.35
GABRD O14764 2/20 0.35
GABRA1 P14867 2/20 0.35
GABRB1 P18505 2/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRA3 P34903 2/20 0.35
GABRA2 P47869 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23537467 1.00 PIM1 (0.49) PIM1PIM3ALDH1A1SMN1; SMN2MAPT
SCHEMBL23537407 0.83 ALDH1A1 (0.44) PIM1PIM3ALDH1A1SMN1; SMN2MAPT
SCHEMBL29824591 0.83 ALDH1A1 (0.44) PIM1PIM3ALDH1A1SMN1; SMN2MAPT
SCHEMBL23537530 0.79 ALDH1A1 (0.47) PIM1PIM3ALDH1A1SMN1; SMN2MAPT
SCHEMBL28798906 0.79 PIM1 (0.59) PIM1PIM3ALDH1A1SMN1; SMN2LMNA
SCHEMBL23537551 0.76 ALDH1A1 (0.47) PIM1PIM3ALDH1A1SMN1; SMN2MAPT
SCHEMBL30023090 0.76 ALDH1A1 (0.47) PIM1PIM3ALDH1A1SMN1; SMN2MAPT
SCHEMBL12789436 0.73 ALDH1A1 (0.46) PIM1PIM3ALDH1A1SMN1; SMN2MAPT
SCHEMBL28871672 0.72 NQO1 (0.32) ALDH1A1CDC25ACDC25CGABRPGABRD
SCHEMBL23537613 0.70 PARP1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4149945-A1 SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2023-03-22 EP disclosed
EP-4076648-A1 SUBSTITUTED BICYCLIC AND TRICYCLIC UREAS AND AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2022-10-26 EP disclosed